Changing the landscape of pediatric cancer
With your support, we have changed the world :
We created a reason for companies to develop drugs for seriously ill kids with rare diseases:
The Pediatric Priority Review Voucher (PRV)We forged paths so that adult oncology drugs are studied in kids:
The RACE for Children Act and
The Mikaela Naylon Give Kids a Chance Act
30% of FDA novel drugs are supported by one of our programs
What we are asking Congress now:
The Mikaela Naylon Give Kids a Chance Act is Passed into Law 2.3.2026
Pediatric PRV reauthorized
Studies of combinations of cancer drugs for kids
5th most cosponsored bill in 119th Congress
The Lede with Jake Tapper · 2.2026
Pediatric Cancer Bill Becomes Law
2.3.2026
Sam Stein
Changing the Landscape of Pediatric Cancer
Kids and young adults changing the landscape of pediatric cancer
Mikaela Naylon,16, MIB Agent at the FDA OSI Workshop, October 2025
Camille Brady, 23, MIB Agents Junior Advisory Board Member
